… SARS-CoV-2 specific cellular immunity was also observed in both mice and non-human
primate … Additionally, vaccination protected rhesus macaques from symptomatic SARS-CoV-2 …

… against SARS-CoV-2 challenge in nonhuman primates. … of non-coding regions in a
SARS-CoV-2 mRNA vaccine can … efficacy against SARS-CoV-2 challenge in nonhuman primates. …

… to various pathogens in both non-human primates and humans. In this … SARS-CoV-2
spike (S) protein, and evaluated their immunogenicity and protective efficacy against SARS-CoV…

… Based on a nonhuman primate (NHP) model of SARS-CoV-2 infection, we developed a
mathematical model for SARS-CoV-2 that describes viral dynamics in both nasopharyngeal and …

… show that viral dynamics of SARS-CoV-2 infection have a … non-human primates. Using
the model we also evaluate the effect of several potential therapeutic interventions for SARS-CoV-…

… pathogenic characteristics of SARS-CoV-2 variants. In addition, nonhuman primates (NHPs)
are suitable animal models for the study of the pathogenic characteristics of SARS-CoV-2 …

… 87G7) that neutralises the SARS-CoV-2 variants of concern (… HuMab 87G7 broadly neutralise
SARS-CoV-2 VOCs in vitro … against the Delta VOC in non-human primates. In summary, …

… a nonhuman primate (NHP) model of SARS-CoV-2 infection. Rhesus macaques are susceptible
to the virus … The macaque model has been widely used to test candidate SARS-CoV-2 …

… nonhuman primates infected with SARS-CoV-2. The different pathological changes in
animal models and human patients upon SARS-CoV-2 infection warrant further investigation. …

… SARS-CoV-2 infection induced protective immunity against reexposure in nonhuman primates…
Given the near-complete protection in all animals after SARS-CoV-2 rechallenge, we were …